Inventor · disambiguated record
Anthony Tutino
Also filed as: TUTINO ANTHONY · TUTINO ANTHONY J
7 granted patents·3 pending applications·85 citations·filing 2010–2020
85Inventor score
Top patents by PatentIndex Score
10 records- 0194US8828427B2Formulations of 4-amino-2-(2,6-dioxopiperidine-3-yl)isoindoline-1,3-dioneTUTINO ANTHONY·Filed 2010·Granted Sep 9, 2014·46 cites·12 claims
- 0288US9198866B2Pharmaceutical formulations of a substituted diaminopurineSIGNAL PHARM LLC·Filed 2013·Granted Dec 1, 2015·15 cites·18 claims
- 0385US8603527B2Pharmaceutical formulations of a substituted diaminopurineBHAT SREENIVAS S·Filed 2011·Granted Dec 10, 2013·18 cites·18 claims
- 0481US9993467B2Formulations of 4-amino-2-(2,6-dioxopiperidine-3-yl)isoindoline-1,3-dioneCELGENE CORP·Filed 2015·Granted Jun 12, 2018·2 cites·8 claims
- 0576US9468605B2Formulations of (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dioneCELGENE CORP·Filed 2014·Granted Oct 18, 2016·1 cites·3 claims
- 0675US9393255B2Pharmaceutical compositions of cytidine analogs and methods of use thereofTUTINO ANTHONY·Filed 2012·Granted Jul 19, 2016·3 cites·36 claims
- 0773US2021085665A1Formulations of 4-amino-2-(2,6-dioxopiperidine-3-yl)isoindoline-1,3-dioneCELGENE CORP·Filed 2020·Application pending·0 cites
- 0870US2020222382A1Formulations of 4-amino-2-(2,6-dioxopiperidine-3-yl)isoindoline-1,3-dioneCELGENE CORP·Filed 2020·Application pending·0 cites
- 0967US10555939B2Formulations of 4-amino-2-(2,6-dioxopiperidine-3-yl)isoindoline-1,3-dioneCELGENE CORP·Filed 2018·Granted Feb 11, 2020·0 cites·8 claims
- 1064US2014336223A1Formulations of 4-amino-2-(2,6-dioxopiperidine-3-yl)isoindoline-1,3-dioneCELGENE CORP·Filed 2014·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →